NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Distribution · USD

Accendra Health, Inc. (ACH) Stock Analysis

Accendra Health, Inc. (ACH) is a Medical Distribution stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

ACH

$0.22

−$0.04 (−14.33%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ACH with… →

ACH Key Statistics

As of Oct 21, 2026
Trading
Open
$0.26
Previous Close
$0.26
Day's Range
0.22–0.26
52-Week Range
0.20–5.60
Volume
2.43M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.57
Valuation
Market Cap
$16.83M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
2.57
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.70
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.44
Financials (FY)
Revenue (FY)
$2.76B+3.06%
Net Income (FY)
−$1.10B
Profit marginThe share of revenue left as profit after all costs and taxes.
−11.41%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
76.90M
1-Year Return
−95.68%
Dividend and dates
Earnings Date
October 29, 2026estimated
Avg Volume
1.70M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, ACH closed at $0.22, −95.68% over 1 year.

Accendra Health, Inc. (ACH) has a market capitalization of $16.83M.

In fiscal 2025, ACH reported revenue of $2.76B.

ACH Stock Return by Calendar Year

Accendra Health, Inc. (ACH) 10-year return: what $10,000 became

1 year
$10,000 $432
−95.68%
5 years
$10,000 $62
−99.38%
10 years
$10,000 $74
−99.26%

If you had invested $10,000 in Accendra Health, Inc. (ACH) 10 years ago, at the close on October 21, 2016, it would have been worth $74 at the close on October 21, 2026: −99.26% in total, −38.81% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−92.19%
2025−78.58%
2024−32.17%
2023−1.33%
2022−55.10%
2021+60.86%
2020+423.96%
2019−18.11%
2018−64.51%
2017−44.44%
2016 (partial year)+2.28%

As of October 21, 2026.

ACH Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.76B−$1.10B−39.8%
2024$2.68B−$362.69M−13.5%
2023$2.55B−$41.30M−1.6%
2022$9.96B$22.39M0.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.76B$1.29B$221.74M−$1.10B−39.8%
2024$2.68B$1.28B$198.04M−$362.69M−13.5%
2023$2.55B$1.22B$215.36M−$41.30M−1.6%
2022$9.96B$1.83B$276.78M$22.39M0.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ACH Dividend History

$0.01+0.0% vs 2020

Dividends per share, 2021 · 4 payments

YearDividends per sharePaymentsChange
2021$0.014+0.0%
2020$0.014+0.0%
2019$0.014−98.6%
2018$0.864−17.2%
YearDividends per sharePaymentsChange
2021$0.014+0.0%
2020$0.014+0.0%
2019$0.014−98.6%
2018$0.864−17.2%
2017$1.034+304.7%
2016$0.261—

Most recent payment: $0.00 per share, ex-dividend December 14, 2021. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

ACH Valuation vs Medical Distribution Median

Median of 11 stocks
MetricACHMedical Distribution medianvs median
P/S ratio0.010.380.0x the median
Profit margin−11.41%−4.73%6.7 pts below

Medians across 11 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 16 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Accendra Health, Inc. (ACH) at $16.83M. It is classified in the Medical Distribution industry, within the Healthcare sector. Headcount on file is 6,500.

ACH last closed at $0.22 on October 21, 2026. That is −$0.04 (−14.33%) against the previous close. Over the past 52 weeks the price has ranged from $0.20 to $5.60. The latest close sits 9.4% above that 52-week low.

Financial Health

In fiscal 2025, Accendra Health, Inc. reported revenue of $2.76B. Against the prior fiscal year total of $2.68B, that is a change of +3.06%. The same year closed with a net loss of $1.10B. The reported profit margin is −11.41%. That is 6.7 percentage points below the Medical Distribution median of −4.73%. Trailing earnings per share are −1.44.

Across the 4 fiscal years on file, revenue moves from $9.96B in 2022 to $2.76B in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 2.57. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.7.

Beta against the wider market is reported at 1.57. Annualized volatility over the trailing 10 years is 80.91%. The trailing one-year total return is −95.68%. Measured over 10 years, that is −38.81% a year compounded.

Growth & Income

The dividend record for ACH runs through 2021. Dividends are recorded for 6 calendar years; 2021 shows 4 payments totalling $0.01 a share. The year before, 2020, totalled $0.01 a share.

2026 is still running; the total return is −92.19% year to date. Across the complete calendar years on file, 2020 returned +423.96% and 2025 returned −78.58%. Of the 9 complete calendar years on file, 2 finished higher.

Peer Comparison

Accendra Health, Inc. (ACH) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Accendra Health, Inc. ACH $16.83M —
McKesson Corporation MCK $118.40B 27.2
Cencora, Inc. COR $64.96B 25.3
Cardinal Health, Inc. CAH $58.83B 35.1

The Medical Distribution industry average P/E ratio is 26.2x. Accendra Health, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Distribution Stocks

MCK

McKesson Corporation

$118.40B

 COR

Cencora, Inc.

$64.96B

 CAH

Cardinal Health, Inc.

$58.83B

 HSIC

Henry Schein, Inc.

$9.47B

 AHG

Akso Health Group

$1.09B

 FOCL

EDAP TMS S.A.

$206.34M
View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Accendra Health, Inc.

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Visit website →